secwatch.observer — SEC 8-K summary
======================================

Issuer:     MANGOCEUTICALS, INC. (MGRX)
CIK:        0001938046
Form:       8-K
Filed at:   2026-10-09T20:01:41+00:00
Accession:  0001493152-26-046510
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Mangoceuticals closes $493K registered direct offering at $0.75/unit, a 74% premium to $0.43 recent close
--------------------------------------------------------------------------------

- Entered Oct. 8, 2026 securities purchase agreement for a registered direct offering of 657,000 shares and warrants to buy 657,000 shares at $0.75 per unit; gross proceeds about $492,750.
- Warrants have a $1.00 exercise price, are exercisable immediately, expire five years from issuance, and allow cashless exercise at 1.08x; holder ownership capped at 4.99% or 9.99%.
- Offering closed Oct. 9, 2026, priced at $0.75 per unit, an approximately 74% premium to the referenced recent closing price of $0.43; no placement agent, underwriter, or financial advisor was used.
- Net proceeds to be used for working capital and general corporate purposes; shares and warrants sold under shelf registration S-3 (No. 333-288039) declared effective June 24, 2025.
- Press release also notes Oct. 1, 2026 subsidiary MangoRx IP Holdings received $1.75M of $2.5M strategic commitments for 25% membership interest; remaining $750,000 due by Nov. 28, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1938046/000149315226046510/0001493152-26-046510-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1938046/000149315226046510/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-046510

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer